TOR THERAPEUTICS INC — Federal Contracts, Awards & Government Contractor Profile

About TOR THERAPEUTICS INC

TOR Therapeutics Inc. is a biotechnology company founded in 2015 by Drs. Jeffrey Melin and Nancy Young, focused on developing a novel fixed dose combination of two mTORC1 inhibitors to treat neurodegenerative diseases, particularly Alzheimer's Disease. Their lead drug, RMF™, is intended as an oral, once-a-day pill for early intervention to maintain cognitive function.

Development of novel fixed dose combination of mTORC1 inhibitorsResearch and development of RMF™, an oral treatment for early-stage Alzheimer's DiseaseClinical trial design and execution for Alzheimer's Disease treatmentsPatent protection for RMF™ through 2036 with new patents being filed

Is this your company?

Claim TOR THERAPEUTICS INC to unlock the federal & state contracts GovIntel's AI has matched to you right now — plus your own scored past-performance, who you're up against, and who's risky to team with.

Claim TOR THERAPEUTICS INC & see your matches

Free to claim. Takes about a minute.

Data compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate, or want this page removed? Request a correction or removal.